Claims for Patent: 9,175,264

Summary for Patent: 9,175,264

Title:	Postnatal stem cells and uses thereof
Abstract:	The invention generally relates to postnatal dental stem cells and methods for their use. More specifically, the invention relates in one aspect to postnatal dental pulp stem cells, use of the cells to generate dentin, and differentiation of the cells. In another aspect, the invention relates to human postnatal deciduous dental pulp multipotent stem cells, use of the cells to generate dentin, and differentiation of the cells.
Inventor(s):	Shi; Songtao (Irvine, CA), Robey; Pamela Gehron (Bethesda, MD), Gronthos; Stan (Colonel Light Gardens, AU), Miura; Masako (Kyoto, JP)
Assignee:	The United States of America as represented by the Secretary of the Department of Health and Human Services (Washington, DC)
Application Number:	10/553,633
Patent Claims:	1. An isolated clonal population of human postnatal deciduous dental pulp multipotent stem cells, wherein the human postnatal deciduous dental pulp multipotent stem cells are from a postnatal deciduous tooth; human postnatal deciduous dental pulp multipotent stem cells in the clonal population differentiate into a neural cell, an adipocyte, or an odontoblast; human postnatal deciduous dental pulp multipotent stem cells in the clonal population can proliferate to over 140 population doublings; and the isolated clonal population of human postnatal deciduous dental pulp multipotent stem cells was expanded ex vivo, wherein the human postnatal deciduous dental pulp multipotent stem cells in the population express CD146. 2. The isolated clonal population of human postnatal deciduous stem cells of claim 1, wherein human postnatal deciduous stem cells within the population induce formation of a significant amount of bone, but do not form bone, when transplanted in vivo. 3. The isolated clonal population of human postnatal deciduous dental pulp multipotent stem cells of claim 1, wherein human postnatal deciduous dental pulp multipotent stem cells within the population express STRO 1. 4. The isolated clonal population of human postnatal deciduous dental pulp multipotent stem cells of claim 1, wherein human postnatal deciduous dental pulp multipotent stem cells within the population generate dentin when transplanted in vivo. 5. The isolated clonal population of human postnatal deciduous dental pulp multipotent stem cells of claim 1, wherein the human postnatal deciduous dental pulp multipotent stem cells are transfected with an exogenous nucleic acid segment that encodes a heterologous product, and wherein the cells express the product. 6. The isolated clonal population of human postnatal deciduous dental pulp multipotent stem cells of claim 1, wherein the postnatal deciduous tooth is an incisor. 7. The isolated clonal population of human postnatal deciduous dental pulp multipotent stem cells of claim 1, obtained by the process of: separating pulp from a remnant crown of a human postnatal deciduous tooth; digesting the pulp in collagenase and dispase to form digested pulp; producing a single cell suspension from the digested pulp; and isolating single cells that adhere to a tissue culture surface from the single cell suspension and culturing the single cells in vitro. 8. An isolated human postnatal deciduous dental pulp multipotent stem cell as deposited with the American Type Culture Collection (ATCC) as PTA-11551, wherein the stem cell induces the formation of bone when transplanted in vivo. 9. A clonal cell isolated from the isolated population of human postnatal deciduous dental pulp multipotent stem cells of claim 1, wherein the clonal cell expresses neural markers when transplanted into the dentate hippocampus of an immunocompromised mouse in vivo. 10. The isolated clonal population of human postnatal deciduous dental pulp multipotent stem cells of claim 1, wherein human postnatal deciduous dental pulp multipotent stem cells within the population do not express STRO-1. 11. A composition comprising a carrier and the cells deposited with the American Type Culture Collection (ATCC) as PTA-11551, wherein the composition induces the formation of bone when transplanted in vivo. 12. The composition of claim 11, consisting of the carrier, a medium, and the cells deposited with the American Type Culture Collection (ATCC) as PTA-11551, wherein the composition induces the formation of bone when transplanted in vivo. 13. A composition comprising a carrier and a mixed population of human postnatal deciduous dental pulp multipotent stem cells that have been cultured ex vivo, induce formation of bone growth when implanted in vivo, and can proliferate for over 140 population doublings, wherein the human postnatal deciduous dental pulp multipotent stem cells in the population express CD146, and a biocompatible three dimensional carrier. 14. The isolated clonal population of human postnatal deciduous stem cells of claim 1, wherein the isolated population is cryopreserved. 15. The isolated clonal population of human postnatal deciduous stem cells of claim 14, wherein the isolated clonal population of human postnatal deciduous dental pulp multipotent stem cells is cryopreserved in liquid nitrogen. 16. A pharmaceutical composition comprising the isolated clonal population of human postnatal deciduous dental pulp multipotent stem cells of claim 1, and a pharmaceutically acceptable carrier, wherein the human postnatal deciduous dental pulp multipotent stem cells survive in the carrier and wherein the pharmaceutical composition is sterile. 17. The pharmaceutical composition of claim 16, wherein the composition is a sterile implantable solution. 18. The composition of claim 13, wherein cells in the population have the capacity to differentiate into a neural cell, an adipocyte, or an odontoblast. 19. The composition of claim 13, wherein cells in the population express STRO-1. 20. The composition of claim 13, wherein cells in the population do not express STRO-1. 21. The isolated clonal population of human postnatal deciduous stem cells of claim 2, wherein human postnatal deciduous dental pulp multipotent stem cells within the population express ALP, matrix extracellular phosphoglycoprotein, basic fibroblast growth factor, endostatin, or any combination thereof when cultured in vitro. 22. The isolated clonal population of human postnatal deciduous stem cells of claim 10, wherein human postnatal deciduous dental pulp multipotent stem cells within the population express ALP, matrix extracellular phosphoglycoprotein, basic fibroblast growth factor, endostatin, or any combination thereof when cultured in vitro. 23. The composition of claim 13, wherein the biocompatible carrier is gelatin, a polyvinyl sponge, a collagen matrix, or a hydroxyapatite/tricalcuim phosphate ceramic. 24. The isolated clonal population of human postnatal deciduous dental pulp multipotent stem cells of claim 5, wherein the product is a growth factor, cytokine or chemokine.

Details for Patent 9,175,264

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Smith & Nephew, Inc.	SANTYL	collagenase	Ointment	101995	06/04/1965		2039-03-29